It Ain't what you do, it's the way you do it: Five golden rules for transforming prostate-specific antigen screening Editorial Article uri icon

Overview

MeSH Major

  • Early Detection of Cancer
  • Prostate
  • Prostate-Specific Antigen
  • Prostatic Neoplasms

abstract

  • The benefit-harm ratio of PSA screening can be dramatically improved by avoiding screening, biopsy and treatment in men who are unlikely to benefit, and by referring men that do need treatment to high volume centers.

publication date

  • January 2014

Research

keywords

  • Editorial

Identity

Digital Object Identifier (DOI)

  • 10.1016/j.eururo.2013.12.049

PubMed ID

  • 24411991

Additional Document Info

start page

  • 188

end page

  • 90

volume

  • 66

number

  • 2